Headquarters
8226 23RD AVE NE, SEATTLE, WA 98115-4528, US
SEATTLE, WA, US
AVM BIOTECHNOLOGY LLC
From the company
AVM Biotechnology is a clinical-stage company founded by Theresa Deisher, Ph.D., developing AVM0703, a proprietary formulation of concentrated dexamethasone that permits very high dosing to activate the release and trigger production of the body's gamma delta TCR+ invariant TCR+ bispecific T lymphocytes and Natural Killer T-like immune cells. The company targets cancer, autoimmune syndromes, acute respiratory distress syndrome (ARDS), and infectious diseases.
Products & services offered
Capabilities 3
Materials 1
Classifications
- Materials (1)
- dexamethasone
- Ownership classifications (2)
- Woman Owned Business, Woman Owned Small Business
Facilities
Send your requirements
Quantities, certifications, and timing.